Company news
EirGenix, Inc. news in 2025
EirGenix, Inc.'s news releases, calls and decks from 2025, newest first.
Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics
December 27, 2025
Correction: EirGenix, Inc.
November 12, 2025
EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A
November 12, 2025